Chemotherapeutic Toxicity Clinical Trials

16 recruiting

Chemotherapeutic Toxicity Trials at a Glance

16 actively recruiting trials for chemotherapeutic toxicity are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Copenhagen, Brussels, and Beijing. Lead sponsors running chemotherapeutic toxicity studies include Rigshospitalet, Denmark, Children's Hospital Los Angeles, and Cancer Institute and Hospital, Chinese Academy of Medical Sciences.

Browse chemotherapeutic toxicity trials by phase

Treatments under study

About Chemotherapeutic Toxicity Clinical Trials

Looking for clinical trials for Chemotherapeutic Toxicity? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chemotherapeutic Toxicity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chemotherapeutic Toxicity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.

PainHead and Neck CancerQuality of Life+6 more
Mucosa Innovations, S.L.63 enrolled1 locationNCT05635929
Recruiting
Not Applicable

Daily Hand-Held Vibration Therapy

CancerChemotherapeutic ToxicityNeuropathy+1 more
Indiana University16 enrolled3 locationsNCT04207437
Recruiting

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025

Chemotherapeutic ToxicityRadiation Toxicity
Bernardino Clavo, MD, PhD105 enrolled1 locationNCT05417737
Recruiting

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Chemotherapeutic ToxicityLymphoma
Sunnybrook Health Sciences Centre188 enrolled1 locationNCT04053439
Recruiting

Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

Chemotherapeutic ToxicityMinimal Residual DiseaseGene Abnormality+1 more
Instituto do Cancer do Estado de São Paulo180 enrolled1 locationNCT05959720
Recruiting
Not Applicable

At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure

Chemotherapeutic ToxicityCardiovascular Complication
Children's Hospital Los Angeles20 enrolled1 locationNCT06826534
Recruiting

Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.

Breast CancerChemotherapeutic ToxicityPaclitaxel Adverse Reaction+3 more
Universitair Ziekenhuis Brussel40 enrolled2 locationsNCT06387901
Recruiting
Phase 3

Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

Hepatocellular CarcinomaChemotherapy EffectChemotherapeutic Toxicity
Sun Yat-sen University540 enrolled1 locationNCT06041477
Recruiting
Not Applicable

Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer

CDK4/6 InhibitorChemotherapeutic ToxicityTrastuzumab+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences148 enrolled1 locationNCT06197581
Recruiting
Phase 1

OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.

Pleural CarcinomatosisQuality of LifeChemotherapy Effect+4 more
Odense University Hospital20 enrolled1 locationNCT06421610
Recruiting
Not Applicable

Comparison of Prophylactic Photobiomodulation Protocols in Chemoinduced Oral Mucositis in Oncology Patients

Chemotherapeutic ToxicityOral MucositisChildhood Cancer
Federal University of Rio Grande do Sul34 enrolled1 locationNCT05811195
Recruiting
Not Applicable

Effects of Exercise Training in Survivors of Lymphoma

CardiotoxicityChemotherapeutic ToxicityLymphoma+2 more
Norwegian School of Sport Sciences280 enrolled2 locationsNCT06270667
Recruiting

Danish Elder Lymphoma Patient Hematopoietic Investigation

Chemotherapeutic ToxicityLymphomaChemotherapy-induced Neutropenia+1 more
Rigshospitalet, Denmark300 enrolled1 locationNCT05245487
Recruiting

Understanding CARdiac Events in Breast Cancer

Breast CancerHeart FailureCardiotoxicity+3 more
National University of Ireland, Galway, Ireland100 enrolled4 locationsNCT05921279
Recruiting

Lower Urinary Tract Symptoms After Intravesical Therapy

Chemotherapy EffectChemotherapeutic ToxicityLower Urinary Tract Symptoms+1 more
Ludwig-Maximilians - University of Munich60 enrolled1 locationNCT05844059
Recruiting

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

CancerHodgkin LymphomaChemotherapeutic Toxicity+3 more
Rigshospitalet, Denmark100 enrolled1 locationNCT05840575